Big Wins for Rare Liver Disease: New Codes, Drug Approvals, and Global Advocacy – Pediatric and Rare Liver Diseases News
The introduction of new, dedicated ICD-10 diagnosis codes for Fontan-associated conditions in the U.S. Centers for Medicare & Medicaid Services (CMS) FY 2026 IPPS Proposed Rule marks a significant step forward for patients who have undergone the Fontan procedure.
Treatment Advances & Prevention Research – Liver Cancer News
Global Liver Institute brings you key updates in liver cancer research and treatment.
Liver Health Insights, Events, and a Global Challenge – Fatty Liver Disease News
I recently conducted a workshop titled: Advanced Strategies: Navigating Credible Research and Accessing Clinical Trial Opportunities, as part of GLI’s A4 ,program with a focus on clinical research participation.
GLI Statement on the CMS 2026 Medicare Advantage and Part D Final Rule on Anti-Obesity Medication Coverage
On Friday, April 4, 2025, the U.S. Centers for Medicare and Medicaid (CMS) released the 2026 Medicare Advantage and Part D Final Rule and decided not to finalize the proposed rule to extend obesity treatment coverage to Medicare and Medicaid beneficiaries.
Administration focuses on health program consolidations and terminates more federal employees, leaving some key health programs without staff – Liver Health Policy Update
Medicaid cuts are still under consideration in Congress as the House pushes for the Senate to accept its version of a budget reconciliation package.